PMID- 27456089 OWN - NLM STAT- MEDLINE DCOM- 20170509 LR - 20170509 IS - 1756-185X (Electronic) IS - 1756-1841 (Linking) VI - 19 IP - 10 DP - 2016 Oct TI - Arthritis in childhood human immunodeficiency virus infection predominantly associated with human leukocyte antigen B27. PG - 1018-1023 LID - 10.1111/1756-185X.12947 [doi] AB - AIM: Children with human immunodeficiency virus (HIV) infection usually present with recurrent and unusual infections. Although reported among adults, arthritis as a predominant presentation in children with HIV is rare. Reactive arthritis is considered to be the most common musculoskeletal manifestation in adults with HIV infection. However, in children, septic or HIV-related arthritis has been described. We report four children having arthritis with HIV disease and their long-term outcome; out of which three had human leukocyte antigen (HLA)-B27-related arthritis. It is important to be aware of arthritic presentation of HIV disease in children to prevent delay in diagnosis and initiation of appropriate therapy. METHODS: Clinical profile of children with HIV infection who presented with arthritis and registered at the Pediatric Immunodeficiency Clinic at PGIMER, Chandigarh were reviewed and analyzed. RESULTS: A total of 796 children with HIV infection are registered in the Pediatric Immunodeficiency Clinic since January 1994. Among these, four children had arthritis, and it was the presenting manifestation in two of them. HLA-B27 related arthritis was noted in three children, while one had HIV-associated arthritis. None of the children had septic arthritis. Arthritis resolved on treatment with antiretroviral therapy (ART) in two children, while others responded to anti-inflammatory agents and the joint symptoms remained quiescent on follow-up with a total follow-up period of 21.5 patient years. CONCLUSIONS: Clinicians must be aware of the arthritic presentation of childhood HIV infection. High degree of suspicion must be entertained to screen for HIV infection in children with arthritis, especially in those with reactive arthritis. CI - (c) 2016 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. FAU - Suri, Deepti AU - Suri D AD - Allergy-Immunology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. surideepti@gmail.com. FAU - Sharma, Avinash AU - Sharma A AUID- ORCID: 0000-0003-4433-4355 AD - Allergy-Immunology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. FAU - Bhattad, Sagar AU - Bhattad S AD - Allergy-Immunology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. FAU - Rawat, Amit AU - Rawat A AD - Allergy-Immunology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. FAU - Arora, Sunil AU - Arora S AD - Department of Immuno-Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. FAU - Minz, Ranjana W AU - Minz RW AD - Department of Immuno-Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. FAU - Singh, Surjit AU - Singh S AD - Allergy-Immunology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. LA - eng PT - Case Reports PT - Journal Article DEP - 20160726 PL - England TA - Int J Rheum Dis JT - International journal of rheumatic diseases JID - 101474930 RN - 0 (Anti-HIV Agents) RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (HLA-B27 Antigen) SB - IM MH - Age Factors MH - Age of Onset MH - Anti-HIV Agents/therapeutic use MH - Anti-Inflammatory Agents, Non-Steroidal/therapeutic use MH - Arthritis, Reactive/diagnosis/drug therapy/*immunology MH - Child MH - Child, Preschool MH - HIV Infections/diagnosis/drug therapy/*immunology/virology MH - HLA-B27 Antigen/*immunology MH - Humans MH - India MH - Male MH - Registries MH - Remission Induction MH - Risk Factors MH - Time Factors MH - Treatment Outcome OTO - NOTNLM OT - ART OT - HLA-B27 OT - reactive arthritis OT - rheumatological EDAT- 2016/10/30 06:00 MHDA- 2017/05/10 06:00 CRDT- 2016/07/27 06:00 PHST- 2016/10/30 06:00 [pubmed] PHST- 2017/05/10 06:00 [medline] PHST- 2016/07/27 06:00 [entrez] AID - 10.1111/1756-185X.12947 [doi] PST - ppublish SO - Int J Rheum Dis. 2016 Oct;19(10):1018-1023. doi: 10.1111/1756-185X.12947. Epub 2016 Jul 26.